BamSEC and AlphaSense Join Forces
Learn More

Gyre Therapeutics Inc.

NASDAQ: GYRE    
Share price (12/24/24): $11.90    
Market cap (12/24/24): $1.113 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 10-Q 6 pages Restated Certificate of Incorporation of Gyre Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Fourth Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Gyre Therapeutics, Inc
12/34/56
EX-3.6(B)
from 10-K 2 pages Gyre Therapeutics, Inc. Certificate of Elimination of Series a Preferred Stock Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from 8-K 21 pages Amended and Restated Bylaws of Gyre Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 5 pages Gyre Therapeutics, Inc. Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Third Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Catalyst Biosciences, Inc
12/34/56
EX-3.1
from 8-K 1 page Catalyst Biosciences, Inc. Certificate of Elimination of Series Y Preferred Stock Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from DEFA14A 5 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Y Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 5 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Y Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 425 1 page Amendment to the Amended and Restated Bylaws of Catalyst Biosciences, Inc
12/34/56
EX-3.2
from 8-K 1 page Amendment to the Amended and Restated Bylaws of Catalyst Biosciences, Inc
12/34/56
EX-3.1
from 425 16 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 16 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 25 pages Amended and Restated Bylaws of Catalyst Biosciences, Inc. (As Amended and Restated June 11, 2020) Amended and Restated Bylaws of Catalyst Biosciences, Inc
12/34/56
EX-3.1
from 8-K 24 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.5
from S-1/A 20 pages Catalyst Biosciences, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Second Certificate of Amendment of the Fourth Amended and Restated Certificate of Incorporation of Catalyst Biosciences, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of the Fourth Amended and Restated Certificate of Incorporation of Targacept, Inc
12/34/56
EX-3.1
from 8-K 21 pages Bylaws of Targacept, Inc. (As Amended and Restated March 5, 2015) Bylaws of Targacept, Inc
12/34/56
EX-3.1
from 425 21 pages Bylaws of Targacept, Inc. (As Amended and Restated March 5, 2015) Bylaws of Targacept, Inc
12/34/56